Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition
This study has been completed.
Study NCT01577914 Information provided by IPCA Laboratories Ltd.
First Received on April 12, 2012. Last Updated on July 5, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interventions listed in this trial
Carvedilol Tablets USP 12.5 mg
More general drug interventions related to this trial
Adrenergic alpha-1 Receptor Antagonists
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Sponsors listed in this trial
IPCA Laboratories Ltd.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers